Gossamer Bio (GOSS) EBT (2018 - 2026)
Gossamer Bio (GOSS) posted quarterly EBT of -$50.1 million for Q1 2026, down 27.56% year-over-year from -$69.1 million in Q1 2025, and down 5.82% quarter-over-quarter from -$47.3 million in Q4 2025.
Gossamer Bio (GOSS) EBT (2018 - 2026) Analysis & Trends
Gossamer Bio's EBT history runs 9 years deep, the most recent figure standing at -$50.1 million for Q1 2026.
- In Q1 2026, EBT fell 27.56% year-over-year to -$50.1 million; the TTM figure through Mar 2026 stood at -$183.9 million (down 247.19% YoY), while the FY2025 annual figure was -$170.5 million, down 206.39% from the prior year.
- EBT for Q1 2026 stood at -$50.1 million, down from -$47.3 million in the prior quarter.
- The five-year high for EBT was $53.7 million in Q2 2024, with the low at -$59.0 million in Q3 2022.
- The 5-year median for EBT is -$47.3 million (2025), against an average of -$40.9 million.
- The sharpest annual moves came in 2024 and 2025: EBT jumped 226.29% in 2024, then tumbled 171.32% in 2025.
- Gossamer Bio's EBT stood at -$58.1 million in 2022, then advanced by 17.18% to -$48.1 million in 2023, then increased by 26.4% to -$35.4 million in 2024, then sank by 33.54% to -$47.3 million in 2025, then fell by 5.82% to -$50.1 million in 2026.
- Business Quant data shows GOSS's EBT at -$50.1 million in Q1 2026, -$47.3 million in Q4 2025, and -$48.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Gossamer Bio | 50.34 Mn | -6.69 Mn | - | -28.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30.59 Mn |
| Mar 31, 2026 | -50.08 Mn |
| Dec 31, 2025 | -47.33 Mn |
| Sep 30, 2025 | -48.22 Mn |
| Jun 30, 2025 | -38.27 Mn |
| Mar 31, 2025 | -39.26 Mn |
| Dec 31, 2024 | -35.44 Mn |
| Sep 30, 2024 | -31.94 Mn |
| Jun 30, 2024 | 53.67 Mn |
| Mar 31, 2024 | -44.74 Mn |
| Dec 31, 2023 | -48.15 Mn |
| Sep 30, 2023 | -40.01 Mn |
| Jun 30, 2023 | -42.50 Mn |
| Mar 31, 2023 | -50.86 Mn |
| Dec 31, 2022 | -58.13 Mn |
| Sep 30, 2022 | -59.03 Mn |
| Jun 30, 2022 | -57.39 Mn |
| Mar 31, 2022 | -57.59 Mn |
| Dec 31, 2021 | -56.64 Mn |
| Sep 30, 2021 | -60.36 Mn |